Dr. Michel Desjardins

 

Dr. Michel Desjardins is a cell biologist and immunologist at Université de Montréal who provided a valuable contribution to the understanding of the immune mechanisms involved in the fight against a variety of diseases over the last 25 years. The work of his group was presented in highly cited articles published in prestigious scientific journals such as Nature, Cell, and Immunity. Recently, Dr. Desjardins, in collaboration with Dr. Trudeau and Dr. Heidi McBride at McGill University, provided the first direct evidence suggesting that autoimmune mechanisms (responsible for the attack of the immune system on our own cells and tissues) are involved in the progression of Parkinson’s disease (PD). This work, published in the journal Cell in 2016, was widely discussed in the field of PD and presented as a new opportunity for the development of therapeutic approaches against the disease. Dr. Desjardins received numerous national and international awards and recognitions such as the Human Proteomics Organization (HUPO) prize for Scientific achievement and a fellowship from the Royal Society of Canada. He is currently a full Professor (Professeur titulaire) at the Département de pathologie et biologie cellulaire of Université de Montréal. He received his Ph.D. from the same institution in 1991, and performed Post-doctoral studies at the European Molecular Biology Laboratory (EMBL) in Heidelberg in Germany from 1991 to 1994. Dr. Desjardins is actively involved in studying the events responsible for the development of PD by looking at the cellular and molecular mechanisms involved in the activation of the immune system during the disease.

 

Dr. Michel Desjardins Grants